FREDERICK, Md., May 7, 2013 /PRNewswire/ -- BioElectronics Corporation (OTC PINK: BIEL), maker of consumer medical electronics, announced today that the World Intellectual Property Organization, International Bureau has published its new patent (#WO2013059804) "Pulsed Electromagnetic Field Device with Adhesive Applicator".
The new patent combines Pulsed Electromagnetic Field (PEMF) Technology with the combining of an adhesive that contains a therapeutic substance such as Salicylate, a Nicotinate Ester, Capsaicin, Isopropanol, Menthol or a combination thereof. In modern medicine, salicylic acid and its derivatives are used as constituents of some rubefacient products. Methyl Salicylate can be used as a liniment to soothe joint and muscle pain; and choline salicylate can be used topically to relieve the pain of mouth ulcers. Therefore, when the PEMF technology is combined with a therapeutic substance, the pain relief is immediate and longer lasting even when the immediate sensation wears off.
"We consistently protect our intellectual property throughout the world with new patents, constant innovation and descriptive pricing", said John Martinez, Director of Engineering. "I am pleased that this is our tenth patent granted to us worldwide."
About BioElectronics Corporation
BioElectronics (www.bielcorp.com) is an award winning developer and manufacturer of advanced medical devices. Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal ailments, the Allay™ Menstrual Cycle Pain Therapy, and RecoveryRx™ for surgical procedures and wound care.
SOURCE BioElectronics Corporation